Though these acquired, mostly non-sense CSF3R mutations were initially thought to contribute to SCN pathogenesis100,101, they were later demonstrated to molecularly annotate a subset of ~80% of SCN patients at high risk for leukemic conversion98,101–105. The gene discussed is CSF3R; the disease is severe congenital neutropenia.